Example: quiz answers
CONSUMER MEDICINE INFORMATION - Medsafe
Page 2of 3 other factors, such as your weight and kidney function. How it is given VANCOMYCIN is usually given as a slow injection into a vein (intravenous drip).
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Read Highlighted Changes Revised March, 2008 i …
www.ilexmedical.com2 NAME ARCHITECT i Vancomycin INTENDED USE The ARCHITECT i Vancomycin assay is an in vitro chemiluminescent microparticle immunoassay (CMIA) for the quantitative measurement of
Reference ID: 3058238
www.accessdata.fda.gov5 10 15 20 25 30 2 . FULL PRESCRIBING INFORMATION . 3 . VANCOCIN ® (vancomycin hydrochloride, USP) CAPSULES . 4 . 1 INDICATIONS AND USAGE . VANCOCIN CAPSULES are indicated for the treatment of
Vancomycin - Jordan University of Science and …
www.just.edu.joVancomycin Usual Diluents D5W, NS,LR Reconstitution Reconstitute vials with 20 mL of SWFI for each 1 g of vancomycin (10 mL/500 mg vial; 20 mL/1 g vial; 100 mL/5 g vial; 200 mL/10 g vial).
VANCOMYCIN 1. Product Name 2. Qualitative and …
www.medsafe.govt.nzPage 2of 11 Vancomycin hydrochloride is not effective by the oral route for other types of infections. For oral administration the parenteral formulation may be used.
Guidelines for Diagnosis, Treatment, and …
gi.orgThe American Journal of GASTROENTEROLOGY VOLUME 108 | APRIL 2013 www.amjgastro.com 480 Surawicz et al. and thus may be useful in timely diagnosis of patients with ileus ( 15 ).